IGF1 and infection: Previous studies have shown that the MT biomarker LPS negatively impacts IGF-1 [41,42], however, in this cohort, LPS concentrations were positively correlated with IGF-1 six and 12 months after PZQ treatment, and not at baseline during active infection.